|Security||ETTX / Entasis Therapeutics Holdings Inc.|
|President and CEO||Perros Manoussos|
Institutional Stock Ownership and Shareholders
Entasis Therapeutics Holdings Inc. (NASDAQ:ETTX) has 0 institutional investors and shareholders that have
filed 13D/G or 13F forms with the Securities Exchange Commission (SEC).
Largest shareholders include
Entasis Therapeutics Holdings Inc. (NASDAQ:ETTX) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.
Related News Stories
Last week’s initial public offering (IPO) action saw 12 companies launch successful offerings that raised $1.2 billion in new capital. A total of six IPOs are scheduled to launch in the coming week seeking a total of $658 million in new capital. (0-1)
The third quarter finished with 12 IPOs raising $1.2 billion, tied for the most active week of the year. Returns varied, but the group averaged a gain of just 1.0%. (0-1)
Emeryville, Calif.-based Gritstone Oncology hits the ground running today on the Nasdaq Exchange after raising $100 million in an initial public offering. (0-2)
as of ET